Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
60-29-7
Molecular formula
C4H10O
Molecular weight
74.12 g/mol
Drug class
Volatile inhalational anaestheticcentral nervous system depressant (historical)
Mechanism of action
Produces general anaesthesia through non-specific CNS depression and modulation of multiple ion channels and neurotransmitter systems, including enhancement of inhibitory transmission. It is highly flammable and has been superseded by safer modern anaesthetics.
Indications / reported uses
Historical use as an inhalational general anaesthetic. Diethyl ether is not a routine contemporary anaesthetic because of flammability, airway irritation and safety concerns. Non-anaesthetic historical uses should not be assigned as current therapeutic indications.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Diethyl Ether PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Diethyl Ether Permitted Daily Exposure (PDE) report (the Diethyl Ether PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Diethyl Ether Occupational Exposure Limit (OEL) report (the Diethyl Ether OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.